跳至主要内容
临床试验/NCT02816697
NCT02816697
已完成
不适用

Implementation of a System-level Tobacco Treatment Intervention in Thoracic Oncology

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 263 人2016年6月1日

概览

阶段
不适用
干预措施
CEASE
疾病 / 适应症
Smoking Cessation
发起方
Dana-Farber Cancer Institute
入组人数
263
试验地点
2
主要终点
Smoking cessation Rate
状态
已完成
最后更新
16天前

概览

简要总结

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

详细描述

In particular the study aims to see if participants are asked about their smoking status and what services are offered if someone indicates being a former or current smoker. Findings from this study will help improve a standard of care at this clinic and allow us to understand what type of tobacco treatment services are preferred by patients. * Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process. * Effectiveness of CEASE will be measured through questionnaires \& biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)

注册库
clinicaltrials.gov
开始日期
2016年6月1日
结束日期
2026年4月1日
最后更新
16天前
研究类型
Interventional
研究设计
Crossover
性别
All

研究者

责任方
Principal Investigator
主要研究者

Mary E. Cooley, Phd

Mary E. Cooley MD

Dana-Farber Cancer Institute

入排标准

入选标准

  • Have an actual or potential diagnosis of thoracic malignancy
  • Able to read and write in English.
  • Current or recent former smoker (defined as having smoked within past 6 months)
  • Must have an active telephone number.

排除标准

  • Former smoker greater than 6 months.
  • Have any of the below conditions needing immediate medical intervention
  • Hypercalcemia causing lethargy and confusion,
  • Acute respiratory distress
  • Dehydration
  • Hypotension

研究组 & 干预措施

Cease-Aim 1

* Cease Implementation * 100 Patients after CEASE Implementation * Exit Interview and Tobacco Use Survey

干预措施: CEASE

Pre Cease Implementation Aim 2

50 Current or former smokers (3 months +/-2 month) patients in usual care (before CEASE implementation) * Tobacco Use Survey (Baseline,1- 6 Months) * Biochemical verification

干预措施: Usual Care Tobacco Treatment Services

After Cease Implementation Aim 2

50 Current or former smokers (3 months +/-2 month) * Tobacco Use Survey (Baseline,1- 6 Months) * Biochemical verification

干预措施: CEASE

Usual Care-Aim 1

Usual Care Tobacco Treatment Services * 100 patients in usual care * Exit Interview and Tobacco Use Survey

干预措施: Usual Care Tobacco Treatment Services

Clinician and Staff Survey

\- Interview clinicians and support staff (40)

结局指标

主要结局

Smoking cessation Rate

时间窗: 6 Months

Biochemical verification of smoking cessation

次要结局

  • Documentation of tobacco treatment(2 months after CEASE)

研究点 (2)

Loading locations...

相似试验